A Familial Case of Multicentric Carpotarsal Osteolysis Syndrome and Treatment Outcome

Abstract

Multicentric carpotarsal osteolysis syndrome (MCTO) is a rare skeletal disorder caused by heterozygous mutations in the MAFB gene (v-maf musculoaponeurotic fibrosarcoma oncogene ortholog B). This is an autosomal dominant condition with a high frequency of sporadic cases. MCTO is characterized by osteolysis of the carpal, metacarpal, and tarsal bones beginning in early childhood with musculoskeletal rheumatologic symptoms such as pain and disability. Renal involvement can be seen in more than half of the patients; from ages 16 months to 42 years and manifests from proteinuria to end-stage renal failure requiring renal transplantation. The association of MAFB gene mutations with this genetic condition has aided in understanding the pathophysiology of the disease. We report here a 7-year-old Caucasian boy and his 33-year-old mother diagnosed with MCTO, with the boy having concomitant juvenile idiopathic arthritis. He was initially diagnosed with arthritis at age 5 years based on bilateral wrist synovial swelling, morning stiffness, and weakness with family history of his mother being diagnosed with erosive psoriatic arthritis leading to limb deformities. Initial therapy for the boy included methotrexate and infliximab with moderate response. Later, during the course of his disease, he underwent a genetic evaluation at age 7 years for history of learning disabilities and dysmorphic features. Maternal evaluation and radiographic examination led to a clinical diagnosis of MCTO in the mother, and subsequent testing for MAFB gene in the son revealed a mutation at c.206C > T (p.Ser69Leu), the most commonly reported genetic change in MCTO. Nevertheless, further imaging still confirmed ongoing arthritis, and therapy was adjusted based on its progression including abatacept, tocilizumab, and pamidronate. Our report highlights the possibility of concomitant inflammatory arthropathy in MCTO.

Keywords

osteolysis - nephropathy - osteoclast - inflammatory process

• References

• 1 Mehawej C, Courcet JB, Baujat G. , et al. The identification of MAFB mutations in eight patients with multicentric carpo-tarsal osteolysis supports genetic homogeneity but clinical variability. Am J Med Genet A 2013; 161A (12) 3023-3029
• 2 Zankl A, Duncan EL, Leo PJ. , et al. Multicentric carpotarsal osteolysis is caused by mutations clustering in the amino-terminal transcriptional activation domain of MAFB. Am J Hum Genet 2014; 94 (04) 643
• 3 Kim K, Kim JH, Lee J. , et al. MafB negatively regulates RANKL-mediated osteoclast differentiation. Blood 2007; 109 (08) 3253-3259
• 4 Shinohara O, Kubota C, Kimura M, Nishimura G, Takahashi S. Essential osteolysis associated with nephropathy, corneal opacity, and pulmonary stenosis. Am J Med Genet 1991; 41 (04) 482-486
• 5 Moriguchi T, Hamada M, Morito N. , et al. MafB is essential for renal development and F4/80 expression in macrophages. Mol Cell Biol 2006; 26 (15) 5715-5727
• 6 Vichi GF, Falcini F, Pierattelli M, Jenuso R, Ceruso M. Case report 401: idiopathic carpal/tarsal osteolysis (ICTO) associated with nephropathy. Skeletal Radiol 1986; 15 (08) 665-671
• 7 Mumm S, Huskey M, Duan S. , et al. Multicentric carpotarsal osteolysis syndrome is caused by only a few domain-specific mutations in MAFB, a negative regulator of RANKL-induced osteoclastogenesis. Am J Med Genet A 2014; 164A [phone]
• 8 Bennett WM, Houghton DC, Beals RC. Nephropathy of idiopathic multicentric osteolysis. Nephron 1980; 25 (03) 134-138
• 9 Lagier R, Rutishauser E. Osteoarticular changes in a case of essential osteolysis; an anatomical and radiological study. J Bone Joint Surg Br 1965; 47: 339-353
• 10 Connor A, Highton J, Hung NA, Dunbar J, MacGinley R, Walker R. Multicentric carpal-tarsal osteolysis with nephropathy treated successfully with cyclosporine A: a case report and literature review. Am J Kidney Dis 2007; 50 (04) 649-654
• 11 Malecha MA, Wilroy Jr RS. Bilateral corneal opacities associated with idiopathic multicentric osteolysis. Cornea 2003; 22 (04) 377-378
• 12 Pai GS, Macpherson RI. Idiopathic multicentric osteolysis: report of two new cases and a review of the literature. Am J Med Genet 1988; 29 (04) 929-936
• 13 Dworschak GC, Draaken M, Hilger A, Born M, Reutter H, Ludwig M. An incompletely penetrant novel MAFB (p.Ser56Phe) variant in autosomal dominant multicentric carpotarsal osteolysis syndrome. Int J Mol Med 2013; 32 (01) 174-178
• 14 Sun K, Barlow B, Malik F, Inglis A, Figgie M, Goodman S. Total hip arthroplasty in a patient with multicentric carpotarsal osteolysis: a case report. HSS J 2016; 12 (02) 177-181
• 15 Whyte MP, Murphy WA, Kleerekoper M, Teitelbaum SL, Avioli LV. Idiopathic multicentric osteolysis. Report of an affected father and son. Arthritis Rheum 1978; 21 (03) 367-376
• 16 Miheller P, Muzes G, Rácz K. , et al. Changes of OPG and RANKL concentrations in Crohn's disease after infliximab therapy. Inflamm Bowel Dis 2007; 13 (11) 1379-1384